stocktools
Offerings // BriaCell Therapeutics Corp.

BCTX offering history

Every offering-related filing in BriaCell Therapeutics Corp.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 323 filings back to Jun 20, 2014.

Last executed offering
Jun 3, 2026
8-K — priced deal (shares or notes)
Last registration (announced)
Jan 13, 2026
S-1MEF — capacity, not a sale
Executed, last 12 months
3
424B pricings + 8-K 3.02 sales
Registered, last 12 months
2
S-1/S-3/F-series registrations
DateFilingWhat it means
Jun 3, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jun 2, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 14, 2026424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jan 13, 2026S-1MEF →REGISTEREDS-1MEF registration — capacity to sell shares, not a sale yet
Jan 13, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 23, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Dec 23, 2025FWP →MARKETINGFree-writing prospectus — offering being marketed
Jul 16, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jul 15, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 11, 2025FWP →MARKETINGFree-writing prospectus — offering being marketed
Jul 10, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jul 9, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jul 8, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jul 8, 2025FWP →MARKETINGFree-writing prospectus — offering being marketed
Apr 28, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Apr 28, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Apr 24, 2025S-1MEF →REGISTEREDS-1MEF registration — capacity to sell shares, not a sale yet
Apr 24, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 23, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Apr 22, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Apr 22, 2025FWP →MARKETINGFree-writing prospectus — offering being marketed
Feb 5, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 4, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 3, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 13, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 12, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 11, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 2, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 12, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 12, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 16, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 31, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 22, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
May 22, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Mar 28, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 21, 2022424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 16, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 26, 2021424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 23, 2021EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Oct 18, 2021424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
BCTX offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full BCTX workspace →
BCTX offering FAQ

When did BCTX last execute an offering?

Per SEC filings, BriaCell Therapeutics Corp.'s most recent priced offering document is a 8-K filed 2026-06-03. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did BCTX last announce or register an offering?

The most recent registration is a S-1MEF filed 2026-01-13. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.